The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1109
July 23, 2001
View Complete Issue         Table of Contents 2019 
Botulinum Toxin for Cervical Dystonia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Botulinum Toxin for Cervical Dystonia
July 23, 2001 (Issue: 1109)
Botulinum toxin type A (Botox - Allergan) and type B (Myobloc - Elan) are now approved by the FDA for treatment of cervical dystonia. Botulinum toxin type A has been approved since 1989 for treatment of strabismus and blepharospasm. It is also used...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Botulinum Toxin for Cervical Dystonia
Article code: 1109c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.